Magnetoencephalography Market Size, Share & Trends Analysis Report By Technology (Superconducting Magnetoencephalography (sMEG), Optically Pumped Magnetometers (OPM)), By Applications (Clinical, Dementia, Autism, Schizophrenia, Multiple Sclerosis, Stroke, Epilepsy, Others, Research), By End-User (Hospitals and Clinics, Research Institutes, Academic Institutions) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Magnetoencephalography Market Size

The global magnetoencephalography market size was valued at USD 323.25 million in 2025 and is projected to grow from USD 342.03 million in 2026 to USD 537.38 million by 2034, registering a CAGR of 5.81% during the forecast period from 2026 to 2034. North America dominated the magnetoencephalography market with a market share of 39.2% in 2025.

Magnetoencephalography (MEG) is a non-invasive brain imaging technique used to measure the magnetic fields produced by neuronal activity in the brain. When neurons in the brain communicate, they generate tiny electrical currents, which in turn create magnetic fields. MEG detects these magnetic fields, providing high-resolution insights into the brain’s electrical activity.

Unlike other brain imaging methods such as EEG (electroencephalography) or MRI (magnetic resonance imaging), MEG offers better spatial resolution, enabling precise localization of brain activity in real-time. This makes it especially valuable for studying brain function, diagnosing neurological disorders, and guiding brain surgery.

MEG is commonly used in research to understand brain functions like sensory processing, cognition, and motor control, as well as in clinical settings for conditions such as epilepsy, brain tumors, and neurodegenerative diseases. It is a powerful tool because it can track fast brain activity with high temporal and spatial accuracy, providing detailed information that helps guide diagnosis and treatment planning.

Technology Insights

Superconducting Magnetoencephalography (sMEG) remains the dominant technology in the market due to its high sensitivity and ability to capture detailed brain activity across large areas. sMEG utilizes superconducting materials to detect minute magnetic fields generated by neural activity. This technology is widely used in both clinical and research applications, particularly for brain mapping during neurosurgical procedures and for understanding neurological disorders. Its precision makes it the preferred choice for neuroscientists studying cognitive functions, sensory processing, and brain disorders such as epilepsy, driving continued market growth.

Request Customizationto receive a tailored report.

Applications Insights

The clinical application segment is the dominant category in the market, with a major focus on diagnosing and treating neurological disorders. Conditions such as epilepsy, stroke, and dementia are leading the demand for MEG in clinical settings, where it helps in non-invasive brain mapping for pre-surgical planning and treatment monitoring. MEG’s ability to provide real-time brain activity data makes it invaluable for physicians in diagnosing complex conditions, enhancing its adoption in hospitals and clinics globally. The clinical segment’s growth is fueled by the increasing prevalence of neurological disorders and advancements in diagnostic technology.

End-User Insights

Hospitals and clinics dominate the market end-user segment, driven by the increasing demand for advanced diagnostic tools in neurology and psychiatry. MEG technology provides crucial insights into brain activity, aiding in the accurate diagnosis of neurological conditions such as epilepsy, stroke, and dementia. The ability to deliver real-time, non-invasive results makes MEG indispensable in clinical settings, particularly in pre-surgical brain mapping. As hospitals continue to upgrade their diagnostic capabilities, the market for MEG in these institutions is expected to expand, facilitating the early detection and treatment of neurological diseases.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America holds a leading position in the global magnetoencephalography market, driven by the robust healthcare infrastructure, increasing research activities, and growing demand for advanced neuroimaging techniques. The U.S. is a key contributor, with major universities, hospitals, and research institutions like the Mayo Clinic and Harvard Medical School actively adopting MEG systems for neurological research and clinical applications.

Moreover, North America benefits from a high number of FDA-approved MEG systems, such as the Elekta Neuromag system, enabling more accurate diagnostics for neurological disorders like epilepsy and brain tumors. With continued investments in medical technologies and neuroscience research, North America is expected to maintain its dominance.

• United States: The U.S. leads the global magnetoencephalography industry due to its robust healthcare infrastructure, advanced research facilities, and high demand for non-invasive brain mapping techniques. The development of MEG systems by companies like CTF MEG and Elekta contributes to the country's dominance. Moreover, increased funding for neuroscience research and applications in neurology and psychiatry, such as the use of MEG for epilepsy diagnosis, supports market growth.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific Magnetoencephalography Market Trends

Asia-Pacific is witnessing significant growth, fueled by increasing healthcare investments, growing awareness, and advancements in neurodiagnostic technologies. Countries like Japan and China are leading the charge, with major hospitals like the National Center for Neurology and Psychiatry in Japan adopting MEG systems for clinical and research purposes. China's rapidly expanding healthcare sector is also seeing a rise in MEG installations, offering promising growth prospects. As the region continues to invest in cutting-edge medical equipment, Asia-Pacific's MEG industry is set for substantial expansion in the coming years.

• China: China's MEG market is expanding rapidly due to the country's emphasis on improving healthcare and advancing medical technology. Investments in neurology and mental health services, including government-backed research initiatives, have led to the adoption of MEG systems in academic institutions and hospitals. The rise of healthcare spending, along with a growing population seeking better medical services, contributes to China’s rising MEG market share.
• Japan: Japan's MEG market is expanding with the adoption of cutting-edge technologies in neurology, psychiatry, and cognitive neuroscience. The country is home to several research institutions that use MEG for brain research, particularly in areas like Alzheimer's disease and brain tumors. Japan’s healthcare sector supports the use of advanced diagnostic tools, and the country's growing elderly population increases the demand for non-invasive brain mapping technologies.
• India: India is witnessing a rise in the MEG industry, driven by increasing research in neurological disorders and improving healthcare infrastructure. With advancements in medical technology and a growing focus on mental health, hospitals and research centers are adopting MEG systems for clinical diagnostics and brain research. Government initiatives, such as the National Health Mission, are further fueling demand for advanced diagnostic tools in the country.
• South Korea: South Korea's MEG market is growing rapidly due to strong government support for medical technology innovation and the presence of top universities and research centers. The country has integrated MEG into its healthcare systems for applications in brain function analysis, particularly in neurodegenerative diseases. The rise of South Korea's medical tourism industry also encourages the adoption of advanced brain diagnostic tools, benefiting the market.

Europe Magnetoencephalography Market Trends

• Germany: Germany is a key player in the market for MEG, primarily due to its advanced medical equipment manufacturing sector and strong research focus in neuroscience. The country's emphasis on healthcare innovation and its support for academic institutions, such as the Max Planck Institute, drives MEG system integration into clinical research. Moreover, Germany’s healthcare policies promote early diagnosis and treatment, further boosting MEG system adoption.
• South Africa: South Africa's MEG industry is slowly expanding, driven by increasing awareness of neurological disorders and the adoption of advanced diagnostic tools in medical centers. South African research institutions are incorporating MEG into their studies of brain functions, particularly in neurodegenerative diseases and mental health disorders. As the country's healthcare system improves, the demand for non-invasive, high-resolution diagnostic techniques like MEG is expected to rise.

Company Market Share

In the global market, companies are focusing on advancing technology, enhancing system affordability, and expanding applications in both research and clinical settings. Leading companies are investing heavily in the development of high-performance MEG systems that offer greater sensitivity, accuracy, and portability, addressing the growing demand for non-invasive brain mapping tools.

York Instruments Ltd.: Emerging Market Player in the Global Magnetoencephalography Market

York Instruments Ltd. is an emerging player in the global MEG market, gaining recognition for its innovative solutions in brain mapping. Based in the UK, the company focuses on providing cost-effective, high-quality MEG systems for both research and clinical applications. Their unique approach includes developing compact, user-friendly MEG devices that offer high sensitivity and accuracy, which makes them suitable for both academic institutions and hospitals.

List of Key and Emerging Players in Magnetoencephalography Market